RecruitingNCT06536998

Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Enrollment

150 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Liver Cancer

Summary

This is the prospective, observational cohort study (Radiogenomics-Liver), which aims to explore the relationship between the imaging information of liver cancer patients, tumor microenvironment and the prognosis of liver cancer patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study explores how imaging scans (CT and MRI) relate to the genetic and biological makeup of liver cancers. By combining imaging patterns with tumor biology, researchers hope to find better ways to predict treatment outcomes for liver cancer patients. **You may be eligible if...** - You are over 18 and being treated for liver cancer at Wuhan Union Hospital (August 2024–August 2027) - You have had at least one CT or MRI scan before treatment - Your liver cancer has been confirmed by tissue biopsy **You may NOT be eligible if...** - Your scan images are poor quality - Your clinical records are incomplete - You have another primary cancer in addition to liver cancer - Your pathological diagnosis is unclear Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.